Inferior Vena Cava Filters Market Report 2025

The inferior vena cava filters market size has grown strongly in recent years. It will grow from $5.43 billion in 2024 to $5.83 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to risen incidence of deep vein thrombosis, growth in aging population, preventive measures for pulmonary embolism, advancements in filter designs, awareness programs and medical education.

The inferior vena cava filters market size is expected to see strong growth in the next few years. It will grow to $8.11 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing surgical procedures and trauma cases, focus on outpatient settings, rise in chronic diseases and comorbidities, global aging population trends, expanded access to healthcare services. Major trends in the forecast period include enhanced thrombus capture capabilities, exploration of alternative anticoagulant therapies, increased collaboration between manufacturers and healthcare providers, continuous regulatory compliance and monitoring, growing awareness and education initiatives.

The projected increase in the prevalence of venous thromboembolism is set to drive the growth of the inferior vena cava filter market. Venous thromboembolism (VTE), characterized by blood clots in the veins with potential severe consequences, underscores the importance of inferior vena cava filters. These medical devices are instrumental in preventing blood clots from reaching critical organs such as the heart or lungs. According to data from the Centers for Disease Control and Prevention in February 2023, an estimated 900,000 individuals could be affected by venous thromboembolism, contributing to 60,000 to 100,000 annual deaths in the United States. Hence, the rise in VTE prevalence is a significant factor propelling the growth of the inferior vena cava filter market.

The growing preference for non-invasive or minimally invasive medical procedures is anticipated to be a key driver for the inferior vena cava filter market. Minimally invasive procedures, which aim to minimize disruption to normal bodily structures, often involve the use of inferior vena cava (IVC) filters to manage and prevent complications associated with conditions such as deep vein thrombosis (DVT) and pulmonary embolism (PE). The American Society of Plastic Surgeons reported in September 2023 that approximately 23.7 million cosmetic minimally invasive procedures were performed in 2022, with a significant surge of 73% observed in Neuromodulator Injections compared to 2019. This trend reflects a growing preference for procedures with reduced invasiveness, thereby contributing to the growth of the inferior vena cava filter market.

The increase in surgical procedures is expected to drive the growth of the inferior vena cava (IVC) filters market in the future. Surgical procedures are medical operations conducted to diagnose, treat, and prevent health issues through physical alterations to tissues and organs. This rise in surgical procedures can be largely attributed to technological advancements in medicine, an expanding elderly population, and a growing prevalence of chronic health conditions. The uptick in surgical operations boosts the IVC filters market by increasing the demand for these devices, which play a crucial role in preventing blood clots during and after surgeries. For example, in September 2023, data from the American Society of Plastic Surgeons (ASPS), a U.S.-based non-profit organization, estimated that the total number of cosmetic surgery procedures rose to 1,575,244 in 2023, representing a 5% increase from 1,498,361 procedures in 2022. Consequently, the rise in surgical procedures is fueling the growth of the inferior vena cava (IVC) filters market.

Leading companies in the inferior vena cava (IVC) filters market are developing advanced IVC filters to enhance patient outcomes and improve filter retrieval rates. IVC filters play a vital role by preventing blood clots from reaching the lungs, thereby reducing the risk of pulmonary embolism in patients who are unable to use blood-thinning medications. For example, in April 2022, Royal Philips, a Netherlands-based health technology company, introduced the CavaClear IVC filter removal laser sheath, providing a minimally invasive solution for safely retrieving embedded IVC filters. By utilizing advanced circumferential tissue ablation, this innovation improves procedural efficiency and decreases the number of retrieval attempts, addressing a significant need in the IVC filter market.

Strategic partnerships have become a prevalent approach for major companies in the inferior vena cava filter market, aiming to extend distribution networks and gain a competitive advantage. These partnerships allow companies to broaden their service offerings, expand market reach, and enhance customer satisfaction through synergies. An illustration of this strategy is the investment by Cordis-X, a manufacturer of interventional cardiovascular technologies, in Adient Medical in June 2022. This $11 million investment is intended to diversify Cordis's product portfolio to address unmet needs in cardiovascular health.

Major companies operating in the inferior vena cava filters market include B. Braun Melsungen AG, Argon Medical Devices Inc., Boston Scientific Corporation, Cook Medical LLC, Braile Biomédica Indústria Comércio e Representações Ltd., Lifetech Scientific Corporation, VENITI Inc., Cordis Corporation, Bard, Becton Dickinson and Company, Cardinal Health Inc., C. R. Bard Inc., LeMaitre Vascular Inc., Medtronic plc, Merit Medical Systems Inc., Teleflex Incorporated, RA Medical Systems, ETEX Corporation, OptiMed Medizinische Instrumente GmbH, Blue Sail Medical Co. Ltd., Penumbra Inc.

North America was the largest region in the inferior vena cava filters market in 2024. The regions covered in the inferior vena cava filters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the inferior vena cava filters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

An inferior vena cava filter is a small device designed to prevent blood clots from reaching the lungs through the inferior vena cava, a large vein in the body. The inferior vena cava is responsible for returning deoxygenated blood to the heart and lungs. The inferior vena cava filter acts as a barrier, capturing any blood clots that may pass through and preventing them from reaching the heart or lungs.

The main product types of inferior vena cava filters include retrievable inferior vena cava (IVC) filters and permanent inferior vena cava (IVC) filters. Retrievable IVC filters allow percutaneous removal when the risk of blood clot resolves. These filters are made from various materials, including non-ferromagnetic and ferromagnetic materials. They are used in various applications such as the treatment of venous thromboembolism (VTE), prevention of pulmonary embolism (PE), and other relevant medical uses. The devices are typically employed by hospitals, ambulatory surgical centers, and other healthcare facilities.

The inferior vena cava filters market research report is one of a series of new reports that provides inferior vena cava filters market statistics, including inferior vena cava filters industry global market size, regional shares, competitors with an inferior vena cava filters market share, detailed inferior vena cava filters market segments, market trends, and opportunities, and any further data you may need to thrive in the inferior vena cava filter industry. This inferior vena cava filters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The inferior vena cava filters market consists of sales of resorbable IVC filters, Polydioxanone (PPDO) IVC filters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.